VINCASAR PFS (VINCRISTINE SULFATE) INJECTION

TEVA

Revision date : 2012-12-04

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

201-770-2/87-78-5

Name of the chemical

mannitol

Concentration

N/A

EC/CAS

231-791-2/7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

General Information

Revision date

2012-12-04

Product name

VINCASAR PFS (VINCRISTINE SULFATE) INJECTION

Chemical name

Vincaleukoblastine, 22-oxo-, sulfate (1 1) (salt)

1.2.2. Uses advised against

Other than Relevant Use

Manufacturer Name

TEVA

Emergency telephone

1-800/424-9300, 01-703-527-3887

Icons in SDS

Company Information

company name

TEVA

e-mail address of the competent person responsible for the Safety Data Sheet

TevaSDSRequest@tevapharm.com

Section 2

SECTION 2: Hazards identification

Product definition

This product is a clear, colorless aqueous solution. Health Hazards WARNING! THIS PRODUCT CONTAINS A CYTOTOXIC AGENT. EXPOSURE BY ALL ROUTES OF EXPOSURE MUST BE AVOIDED. In the workplace, may be harmful by inhalation and eye or skin contact. May be harmful by ingestion and injection. There are scientific studies that suggest that personnel (e.g. nurses, pharmacists, etc.) who prepare and administer parenteral antineoplastics (e.g. in hospitals) may be at some risk due to potential mutagenicity,

Teratogenic Effects

and/or carcinogenicity of these materials if workplace exposures are not properly controlled. The actual risk in the workplace is not known. In therapeutic use, the most common adverse effects have been diarrhea, anorexia, nausea and vomiting. May also cause allergic reaction including anaphylactoid reaction. In therapeutic use, this material has caused adverse effects on the blood system, bone marrow, digestive, respiratory, neurological and reproductive systems. The most common adverse reaction is hair loss; the most troublesome adverse reactions are neuromuscular in origin. May cause harm to fetus during pregnancy. Limited evidence of adverse effects on fertility in both genders. Limited evidence of carcinogenic effects. These effects may be possible as a result of workplace exposure. Refer to

TOXICOLOGICAL INFORMATION

for additional information on adverse effects. Flammability Hazards This product is not flammable or combustible. When involved in a fire, this product may decompose and produce irritating vapors and toxic compounds (including carbon, sulfur and nitrogen oxides). Reactivity Hazards: This product is not reactive.

Environmental hazards

The active ingredient of this product is harmful to aquatic organisms and may cause harm to animals and aquatic organisms if accidentally released to the environment. Emergency Recommendations: Emergency responders must wear personal protective equipment suitable for the situation to which they are responding.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.